Serplus Technology LLC

SerPlus Technology LLC is a Belmont, California-based company founded in 2010 that specializes in the production and sale of purified plasma proteins, recombinant proteins, peptides, and antibodies, with a primary focus on the serpin protein family. The company provides specialized contract services, utilizing its expertise in recombinant protein expression and purification technologies to support clients in basic and translational research. Their capabilities include expression and purification from yeast, E. coli, and CHO cells, as well as protein process development and assay development, such as protease inhibition and enzyme activity testing.

The company supports partners in the life sciences industry by managing and outsourcing protein production projects from early-stage research through the manufacturing of clinical-grade products. In addition to its commercial offerings, SerPlus has engaged in federally-funded research through Small Business Innovation Research (SBIR) awards from the National Institutes of Health (NIH), focusing on therapeutic applications for proteins like Serpin B1 in areas such as asthma and autoimmune diabetes. Beyond its technical production services, the firm provides consulting expertise in cost-effective project management and outsourcing to preclinical contract research organizations (CROs).